{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:31:51Z","timestamp":1793417511155,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11095-026-04062-y","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:17:09Z","timestamp":1778523429000},"page":"1487-1500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune Efficacy of a Vaccine Candidate Based on Binding Protein 26 (BP26) from Brucella melitensis Encapsulated in Niosome Nanoparticles Against Brucellosis"],"prefix":"10.1007","volume":"43","author":[{"given":"Kimia","family":"Talebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Chiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehri","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Samadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MR","family":"Asadi Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"2","key":"4062_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s12026-022-09346-0","volume":"71","author":"K Jalal","year":"2023","unstructured":"Jalal K, Khan K, Uddin R. Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella suis 1300. Immunol Res. 2023;71(2):247\u201366.","journal-title":"Immunol Res"},{"key":"4062_CR2","doi-asserted-by":"publisher","first-page":"1408407","DOI":"10.3389\/fcimb.2024.1408407","volume":"14","author":"Y Qin","year":"2024","unstructured":"Qin Y, Zhou G, Jiao F, Cheng C, Meng C, Wang L, et al. Brucella mediates autophagy, inflammation, and apoptosis to escape host killing. Front Cell Infect Microbiol. 2024;14:1408407.","journal-title":"Front Cell Infect Microbiol"},{"key":"4062_CR3","doi-asserted-by":"publisher","first-page":"1511949","DOI":"10.3389\/fimmu.2024.1511949","volume":"15","author":"MTR Gomes","year":"2025","unstructured":"Gomes MTR, Guimar\u00e3es ES, Oliveira SC. ZBP1 senses Brucella abortus DNA triggering type I interferon signaling pathway and unfolded protein response activation. Front Immunol. 2025;15:1511949.","journal-title":"Front Immunol"},{"issue":"01","key":"4062_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40249-021-00801-y","volume":"10","author":"D Bugybayeva","year":"2021","unstructured":"Bugybayeva D, Kydyrbayev Z, Zinina N, Assanzhanova N, Yespembetov B, Kozhamkulov Y, et al. A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model. Infect Dis Poverty. 2021;10(01):56\u201365.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"4062_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12866-025-03943-3","volume":"25","author":"X Cao","year":"2025","unstructured":"Cao X, Liu P, Wu J, Liu Z, Zhang Y, Yin C, et al. Genome phylogenetic analysis of Brucella melitensis in Northwest China. BMC Microbiol. 2025;25(1):208.","journal-title":"BMC Microbiol"},{"key":"4062_CR6","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez FM, Bialer MG, Cerruti ML, Estein SM, Ramis LY, Baldi PC et al. Brucella suis \u0394 mapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection. Front. Immunol. 2025;15:1501791.","DOI":"10.3389\/fimmu.2024.1501791"},{"key":"4062_CR7","doi-asserted-by":"crossref","unstructured":"Pirhajati R, Chiani M, Habibi M, Emami T, Shahrokhi N, Karam MRA. Successful prophylactic against Brucella melitensis using a vaccine candidate consisting of recombinant antigens OMP19 and L7\/L12 loaded in a nanoliposomal adjuvant system in a mouse model. Int. J. Pharm. 2025;126372.","DOI":"10.1016\/j.ijpharm.2025.126372"},{"key":"4062_CR8","doi-asserted-by":"publisher","first-page":"925773","DOI":"10.3389\/fvets.2022.925773","volume":"9","author":"M Heidary","year":"2022","unstructured":"Heidary M, Dashtbin S, Ghanavati R, Mahdizade Ari M, Bostanghadiri N, Darbandi A, et al. Evaluation of brucellosis vaccines: a comprehensive review. Front Vet Sci. 2022;9:925773.","journal-title":"Front Vet Sci"},{"key":"4062_CR9","doi-asserted-by":"crossref","unstructured":"He Y, Xiang Z, editors. Bioinformatics analysis of Brucella vaccines and vaccine targets using VIOLIN. Immunome Res.2010;6 Suppl 1):S5 Springer.","DOI":"10.1186\/1745-7580-6-S1-S5"},{"issue":"6","key":"4062_CR10","first-page":"879","volume":"56","author":"J Wen","year":"2024","unstructured":"Wen J, Li Z, Lv Y, Ding S, Zhu Y, Yang J, et al. A subunit vaccine based on Brucella rBP26 induces Th1 immune responses and M1 macrophage activation: Th1 and M1 activation by rBP26 Brucella vaccine. Acta Biochim Biophys Sin. 2024;56(6):879.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"11","key":"4062_CR11","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1128\/IAI.73.11.7297-7303.2005","volume":"73","author":"X Yang","year":"2005","unstructured":"Yang X, Hudson M, Walters N, Bargatze RF, Pascual DW. Selection of protective epitopes for Brucella melitensis by DNA vaccination. Infect Immun. 2005;73(11):7297\u2013303.","journal-title":"Infect Immun"},{"issue":"8","key":"4062_CR12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1080\/14760584.2021.1945448","volume":"20","author":"CP Karch","year":"2021","unstructured":"Karch CP, Matyas GR. The current and future role of nanovaccines in HIV-1 vaccine development. Expert Rev Vaccines. 2021;20(8):935\u201344.","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"4062_CR13","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1021\/acs.nanolett.3c01241","volume":"23","author":"X Xin","year":"2023","unstructured":"Xin X, Liu Y, Guo L, Wang H, Lu D, Chang Y, et al. Improvement of B cell responses by an HIV-1 amphiphilic polymer nanovaccine. Nano Lett. 2023;23(9):4090\u20134.","journal-title":"Nano Lett"},{"key":"4062_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.imlet.2019.01.010","volume":"207","author":"M Abkar","year":"2019","unstructured":"Abkar M, Alamian S, Sattarahmady N. A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of Brucella melitensis Omp31. Immunol Lett. 2019;207:28\u201335.","journal-title":"Immunol Lett"},{"issue":"6","key":"4062_CR15","doi-asserted-by":"publisher","first-page":"2119020","DOI":"10.1080\/21645515.2022.2119020","volume":"18","author":"Q Yin","year":"2022","unstructured":"Yin Q, Wang Y, Xiang Y, Xu F. Nanovaccines: merits, and diverse roles in boosting antitumor immune responses. Hum Vaccin Immunother. 2022;18(6):2119020.","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"4062_CR16","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3390\/pharmaceutics17111434","volume":"17","author":"K Vardar","year":"2025","unstructured":"Vardar K, Kara N, Ozayman NM, Gocucu K, Eren SF, Plevneli M, et al. Efficiency of Calcium Fructoborate-Loaded Novel Natural Niosomes Compared to Traditional Liposomes and Niosomes in Rat Ischemia-Reperfusion Injury Model. Pharmaceutics. 2025;17(11):1434.","journal-title":"Pharmaceutics"},{"issue":"17","key":"4062_CR17","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.3390\/molecules30173467","volume":"30","author":"AA Bautista-Solano","year":"2025","unstructured":"Bautista-Solano AA, D\u00e1vila-Ortiz G, Perea-Flores MdJ, Mart\u00ednez-Ayala AL. A comprehensive review of niosomes: composition, structure, formation, characterization, and applications in bioactive molecule delivery systems. Molecules. 2025;30(17):3467.","journal-title":"Molecules"},{"issue":"1","key":"4062_CR18","doi-asserted-by":"publisher","first-page":"41540","DOI":"10.1038\/s41598-025-25493-4","volume":"15","author":"E Molaakbari","year":"2025","unstructured":"Molaakbari E, Sharifi I, Khosravi A, Salarkia E, Aallaei MR, Keyhani A, et al. Synthesis, characterization, and comparative evaluation of hydroxychloroquine and its niosomal nanoformulation: anti-leishmanial, cytotoxicity, and immunomodulatory effects in photodynamic therapy. Sci Rep. 2025;15(1):41540.","journal-title":"Sci Rep"},{"issue":"11","key":"4062_CR19","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/pharmaceutics11110612","volume":"11","author":"CG Kim","year":"2019","unstructured":"Kim CG, Kye Y-C, Yun C-H. The role of nanovaccine in cross-presentation of antigen-presenting cells for the activation of CD8+ T cell responses. Pharmaceutics. 2019;11(11):612.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4062_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/pharmaceutics17010067","volume":"17","author":"SM Mawazi","year":"2025","unstructured":"Mawazi SM, Ge Y, Widodo RT. Niosome preparation techniques and structure\u2014an illustrated review. Pharmaceutics. 2025;17(1):67.","journal-title":"Pharmaceutics"},{"key":"4062_CR21","doi-asserted-by":"publisher","first-page":"100837","DOI":"10.1016\/j.mtbio.2023.100837","volume":"23","author":"A Moammeri","year":"2023","unstructured":"Moammeri A, Chegeni MM, Sahrayi H, Ghafelehbashi R, Memarzadeh F, Mansouri A, et al. Current advances in niosomes applications for drug delivery and cancer treatment. Mater Today Bio. 2023;23:100837.","journal-title":"Mater Today Bio"},{"issue":"S1","key":"4062_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4142\/jvs.2017.18.S1.281","volume":"18","author":"J Lalsiamthara","year":"2017","unstructured":"Lalsiamthara J, Lee JH. Development and trial of vaccines against Brucella. J Vet Sci. 2017;18(S1):281\u201390.","journal-title":"J Vet Sci"},{"key":"4062_CR23","doi-asserted-by":"publisher","first-page":"903890","DOI":"10.3389\/fvets.2022.903890","volume":"9","author":"A Darbandi","year":"2022","unstructured":"Darbandi A, Alamdary SZ, Koupaei M, Ghanavati R, Heidary M, Talebi M. Evaluation of immune responses to Brucella vaccines in mouse models: a systematic review. Front Vet Sci. 2022;9:903890.","journal-title":"Front Vet Sci"},{"issue":"3","key":"4062_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.7774\/cevr.2024.13.3.232","volume":"13","author":"F Sharif","year":"2024","unstructured":"Sharif F, Nazari R, Fasihi-Ramandi M, Taheri RA, Zargar M. Intranasal and intraperitoneal immunization against Brucella infection using niosome and mannosylated niosomes containing Brucella recombinant trigger factor\/Bp26\/Omp31 chimeric protein in a mouse model. Clin Exp Vaccine Res. 2024;13(3):232.","journal-title":"Clin Exp Vaccine Res"},{"issue":"7","key":"4062_CR25","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1039\/D0BM01518K","volume":"9","author":"F Rezaei","year":"2021","unstructured":"Rezaei F, Keshvari H, Shokrgozar MA, Doroud D, Gholami E, Khabiri A, et al. Nano-adjuvant based on silk fibroin for the delivery of recombinant hepatitis B surface antigen. Biomater Sci. 2021;9(7):2679\u201395.","journal-title":"Biomater Sci"},{"key":"4062_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jconrel.2024.03.053","volume":"369","author":"A Dikpati","year":"2024","unstructured":"Dikpati A, Maio VDP, Ates E, Greffard K, Bertrand N. Studying the stability of polymer nanoparticles by size exclusion chromatography of radioactive polymers. J Control Release. 2024;369:394\u2013403.","journal-title":"J Control Release"},{"issue":"1","key":"4062_CR27","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ijpharm.2017.09.028","volume":"532","author":"AB Jindal","year":"2017","unstructured":"Jindal AB. The effect of particle shape on cellular interaction and drug delivery applications of micro-and nanoparticles. Int J Pharm. 2017;532(1):450\u201365.","journal-title":"Int J Pharm"},{"issue":"1","key":"4062_CR28","doi-asserted-by":"publisher","first-page":"015005","DOI":"10.1088\/1758-5090\/abbb82","volume":"13","author":"F Rezaei","year":"2020","unstructured":"Rezaei F, Damoogh S, Reis RL, Kundu SC, Mottaghitalab F, Farokhi M. Dual drug delivery system based on pH-sensitive silk fibroin\/alginate nanoparticles entrapped in PNIPAM hydrogel for treating severe infected burn wound. Biofabrication. 2020;13(1):015005.","journal-title":"Biofabrication"},{"issue":"2","key":"4062_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1515\/ntrev-2016-0009","volume":"6","author":"R Yasmin","year":"2017","unstructured":"Yasmin R, Shah M, Khan SA, Ali R. Gelatin nanoparticles: a potential candidate for medical applications. Nanotechnol Rev. 2017;6(2):191\u2013207.","journal-title":"Nanotechnol Rev"},{"issue":"3","key":"4062_CR30","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/vaccines3030638","volume":"3","author":"A Taki","year":"2015","unstructured":"Taki A, Smooker P. Small wonders\u2014the use of nanoparticles for delivering antigen. Vaccines. 2015;3(3):638\u201361.","journal-title":"Vaccines"},{"key":"4062_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-015-0195-2","volume":"22","author":"S Derman","year":"2015","unstructured":"Derman S, Mustafaeva ZA, Abamor ES, Bagirova M, Allahverdiyev A. Preparation, characterization and immunological evaluation: canine parvovirus synthetic peptide loaded PLGA nanoparticles. J Biomed Sci. 2015;22:1\u201312.","journal-title":"J Biomed Sci"},{"key":"4062_CR32","doi-asserted-by":"crossref","unstructured":"Gogoi H, Mani R, Bhatnagar R. A niosome formulation modulates the Th1\/Th2 bias immune response in mice and also provides protection against anthrax spore challenge. Int. J. Nanomed. 2018;7427\u20137440.","DOI":"10.2147\/IJN.S153150"},{"key":"4062_CR33","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3389\/fimmu.2019.01759","volume":"10","author":"R L\u00f3pez-Santiago","year":"2019","unstructured":"L\u00f3pez-Santiago R, S\u00e1nchez-Arg\u00e1ez AB, De Alba-N\u00fa\u00f1ez LG, Baltierra-Uribe SL, Moreno-Lafont MC. Immune response to mucosal brucella infection. Front Immunol. 2019;10:1759.","journal-title":"Front Immunol"},{"issue":"15","key":"4062_CR34","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1016\/j.vaccine.2011.01.090","volume":"29","author":"N Surendran","year":"2011","unstructured":"Surendran N, Sriranganathan N, Lawler H, Boyle SM, Hiltbold EM, Heid B, et al. Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB\/c mice. Vaccine. 2011;29(15):2749\u201355.","journal-title":"Vaccine"},{"key":"4062_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.copbio.2020.06.015","volume":"66","author":"G Du","year":"2020","unstructured":"Du G, Sun X. Engineering nanoparticulate vaccines for enhancing antigen cross-presentation. Curr Opin Biotechnol. 2020;66:113\u201322.","journal-title":"Curr Opin Biotechnol"},{"issue":"4-5","key":"4062_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ijmm.2017.03.004","volume":"307","author":"M Golshani","year":"2017","unstructured":"Golshani M, Rafati S, Nejati-Moheimani M, Pourabdi S, Arsang A, Bouzari S. Protein\/protein, DNA\/DNA and DNA\/protein based vaccination strategies using truncated Omp2b against Brucella infection in BALB\/c mice. Int J Med Microbiol. 2017;307(4\u20135):249\u201356.","journal-title":"Int J Med Microbiol"},{"issue":"8","key":"4062_CR37","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.vaccine.2012.12.043","volume":"31","author":"D Goel","year":"2013","unstructured":"Goel D, Rajendran V, Ghosh PC, Bhatnagar R. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544. Vaccine. 2013;31(8):1231\u20137.","journal-title":"Vaccine"},{"issue":"8","key":"4062_CR38","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.4049\/jimmunol.1302561","volume":"192","author":"M-A Vitry","year":"2014","unstructured":"Vitry M-A, Hanot Mambres D, De Trez C, Akira S, Ryffel B, Letesson J-J, et al. Humoral immunity and CD4+ Th1 cells are both necessary for a fully protective immune response upon secondary infection with Brucella melitensis. J Immunol. 2014;192(8):3740\u201352.","journal-title":"J Immunol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04062-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04062-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04062-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:31:12Z","timestamp":1781537472000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04062-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4062"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04062-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no identifiable conflicting financial interests or personal relationships that could potentially have influenced the findings presented in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}